PPAR Agonists and Metabolic Syndrome: An Established Role?

PPAR Agonists and Metabolic Syndrome: An Established Role?

Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated receptors (PPARs) are involved in the metabolic regulation of lipid and lipoprotein levels, i.e., triglycerides (TGs), blood gluco...

Full description

Bibliographic Details
Main Authors: Margherita Botta, Matteo Audano, Amirhossein Sahebkar, Cesare R. Sirtori, Nico Mitro, Massimiliano Ruscica
Format: Article
Language:English
Published: MDPI AG 2018-04-01
Series:International Journal of Molecular Sciences
Subjects:
metabolic syndrome
PPARs
pemafibrate
elafibrinor
Online Access:http://www.mdpi.com/1422-0067/19/4/1197

Internet

http://www.mdpi.com/1422-0067/19/4/1197

Similar Items